Cloniprazepam
Benzodiazepine drug
From Wikipedia, the free encyclopedia
Cloniprazepam is a benzodiazepine derivative and a prodrug of clonazepam, 7-aminoclonazepam, and other metabolites.[1][2]
Other names1-Cyclopropylmethylclonazepam, Kloniprazepam, 2-Chloro-7'-nitroprazepam
Legal status
- CA: Schedule IV
- DE: NpSG (Industrial and scientific use only)
- UK: Schedule 1
| Clinical data | |
|---|---|
| Other names | 1-Cyclopropylmethylclonazepam, Kloniprazepam, 2-Chloro-7'-nitroprazepam |
| Drug class | Benzodiazepines |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C19H16ClN3O3 |
| Molar mass | 369.81 g·mol−1 |
| 3D model (JSmol) | |
| |
| |

Some of the minor metabolites include 3-hydroxyclonazepam and 6-hydroxyclonazepam, 3-hydroxycloniprazepam and ketocloniprazepam with ketone group formed where 3-hydroxy group was.[1]
It is a designer drug and an NPS (short for "new psychoactive substance").[1] At the end of 2017, cloniprazepam was an uncontrolled substance in most of the countries.